There is no ideal tumor marker for pancreatic carcinoma. Most of the tumor-associated antigens in this disease are cell surface mucins, such as CA19-9, TAG-72, CA242, CA50, CA195, and CA494. CA19-9 is the most promising marker. It is used for clinical and pathological diagnosis, prognosis, and respo
Clinical usefulness of computer-assisted diagnosis using combination assay of tumor markers for pancreatic carcinoma
โ Scribed by Seiji Saito; Kuniko Taguchi; Nobuyuki Nishimura; Akiharu Watanabe; Kazuei Ogoshi; Masayuki Niwa; Toshihito Furukawa; Masayoshi Takahashi
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 675 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## BACKGROUND, This study was performed to evaluate the utility of serum and cyst fluid analysis for enzymes (amylase and lipase) and tumor markers (carcinoembiyonic antigen, CA CA 125, in the differential diagnosis of cystic pancreatic lesions. ## METHODS. Serum and cyst fluid were obtained fr
## Abstract ## BACKGROUND Early detection of pancreatic carcinoma is difficult even with current diagnostic tools. Novel biomarkers and detection techniques are urgently needed. Telomerase activity is a promising diagnostic marker. However, the conventional telomeric repeat amplification protocol